Skip to main content

Month: July 2020

Telefónica Deutschland entscheidet sich bei der Umstellung seiner Poststellen-Dokumentenmanagementlösung für Conduent

LONDON, Großbritannien und FLORHAM PARK, N.J., July 08, 2020 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT) hat heute bekannt gegeben, dass sich der Telekommunikationsanbieter Telefónica Deutschland, der größte deutsche Mobilfunkanbieter, bei der Implementierung einer digitalen Poststellen-Dokumentenmanagementlösung für Conduent entschieden hat. Das System soll jährlich 3,5 Millionen eingehende Kundenanfragen verarbeiten.Mit der Lösung von Conduent kann Telefónica Deutschland schneller auf Kundenfragen reagieren und die Kundenzufriedenheit erhöhen.Die Lösung von Conduent besteht aus einer Kombination von Mitarbeitern, Prozessen und Technologien und bietet folgende Leistungen:Öffnen und Vorbereiten aller eingehenden Briefe und Faxe – das sind pro Werktag etwa 10.000 bis 15.000 Briefe und Faxe, die von Anfragen wie Informationsänderungen...

Continue reading

Nevada Exploration and Austin Gold Complete Earn-In Agreement at Kelly Creek Gold Project, Battle Mountain Mining District, Nevada

RENO, Nev., July 08, 2020 (GLOBE NEWSWIRE) — Nevada Exploration Inc. (“NGE” or the “Company”) (TSX-V: NGE; OTCQB: NVDEF) is pleased to announce that it has executed the definitive Exploration and Option to Enter Joint Venture Agreement (the “Agreement”) with Austin Gold Corp. (“Austin Gold”), led by former Pretium Resources Inc. CEO Joe Ovsenek, on its district-scale Kelly Creek Project (the “Project”) within the Kelly Creek Basin in north-central Nevada.  Under the Agreement, Austin has the right to earn a 51% interest in the joint venture by spending $5,000,000 over four years, of which $1,000,000 is a firm commitment, with the election to then earn an additional 19% by delivering a prefeasibility study.  Austin has also completed a $500,000 private placement into NGE.Discussing the Project, Austin’s Executive Chairman, Joe Ovsenek:...

Continue reading

Orbit International’s Electronics Group Reports Second Quarter Bookings in Excess of $4,000,000

HAUPPAUGE, New York, July 08, 2020 (GLOBE NEWSWIRE) — Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that bookings for its Electronics Group (“OEG”) for the second quarter of 2020 exceeded $4,000,000.       Second quarter bookings for its OEG were highlighted by (i) an approximately $970,000 previously announced order for keyboards used on a major military aviation program; (ii) an approximately $939,000 follow-on order received in June for a switch panel received from a major military customer and; (iii) an approximately $560,000 previously announced follow-on order received by our Q-Vio subsidiary for a major program with the U.S. Army. Other orders received during the quarter for the OEG consisted primarily of displays, control panels and repairs.  Deliveries...

Continue reading

Ex-date for the decrease of the share capital of Nordic Fibreboard AS

Nordic Fibreboard AS (trading code SKN1T, ISIN code EE31000922503) will close the list of shareholders for the decrease of the share capital on July 10 2020 at the end of the working day of the settlement system.Proceeding from the above, the ex-date for the change of the rights related with the securities is 09 July 2020.The nominal value of Nordic Fibreboard AS shares will be changed from 0,60 EUR to 0,06 EUR. The share capital of Nordic Fibreboard AS will be decreased by 2 429 492,94 euros, the new share capital after the decrease of the share capital and the change of the nominal value of the shares is 269 943,66 euros, divided into 4 499 061 shares with a nominal value of 0.06 EUR per share. Torfinn LosvikCEO & Chairman of the Management BoardPhone: + 372 56 99 09 88E-mail: torfinn.losvik@nordicfibreboard.com

Continue reading

Nordic Fibreboard AS aktsikapitali vähendamise ex-päev

Nordic Fibreboard AS ( väärtpaberi lühinimi SKN1T, ISIN kood ISIN EE3100092503) fikseerib aktsionäride nimekirja aktsiakapitali vähendamiseks 10.07.2020 arveldussüsteemi tööpäeva lõpu seisuga.Ülaltoodust lähtudes on väärtpaberitega seotud õiguste muutmise päev ( ex-päev) 09.07.2020Nordic Fibreboard AS aktsiate nominaalväärtus muudetakse 0,60 eurolt 0,06 eurole. Nordic Fibreboard AS aktsiakapitali vähendatakse 2 429 492,94 euro võrra, aktsiakapitali uueks suuruseks pärast aktsiakapitali vähendamist ja aktsiate nominaalväärtuse muutmist on 269 943,66 eurot, mis jaguneb 4 499 061 aktsiaks nominaalväärtusega 0,06 eurot aktsia. Torfinn LosvikJuhatuse esimeesTelefon: + 372 56 99 09 88E-mail: torfinn.losvik@nordicfibreboard.com 

Continue reading

Weyland Tech’s AtozGo Partners with Global Fintech Provider for Food Delivery Service in Jakarta

NEW YORK, July 08, 2020 (GLOBE NEWSWIRE) — Weyland Tech, Inc. (OTCQX: WEYL), a leading global provider of eCommerce, mCommerce and fintech business enablement solutions, has partnered with an NYSE-traded global consumer internet company to offer its AtozGo™ food and grocery delivery service to the partner’s large and growing fintech user base in Jakarta, Indonesia.Access to the AtozGo delivery service, which is currently available for both office and residential customers, will be integrated into the partner’s mobile e-wallet app, allowing users to transact AtozGo orders within the app. Through this integration, AtozGo will gain access to the hundreds of thousands of merchants and millions of users already on the partner’s platform.This will represent the partner’s foray into the food and grocery delivery market in Southeast Asia....

Continue reading

Recce Pharmaceuticals Announces RECCE® Compounds Selected by CSIRO/Doherty Institute in Priority 1 Candidate Group for SARS-CoV-2 Antiviral Screening Program

Highlights:RECCE® 327 and New RECCE® 529 compounds were selected for their unique mechanisms of action against hyper-mutation, as indicated on bacteria and viruses (respectively)Testing program will be conducted by CSIRO & University of Melbourne at the Doherty InstituteTherapeutic antiviral treatment focus of RECCE® 327 and RECCE® 529 may see added potential benefit against secondary bacterial infectionsSYDNEY, Australia, July 08, 2020 (GLOBE NEWSWIRE) — Recce Pharmaceuticals Ltd (ASX: RCE) (Company), the Company developing new classes of synthetic anti-infectives, today announced it has entered into an Antiviral SARS-CoV-2 Screening Program Agreement with The Commonwealth Scientific and Industrial Research Organisation (CSIRO) and the University of Melbourne at The Peter Doherty Institute for Infection and Immunology (‘Doherty...

Continue reading

Corbus Pharmaceuticals Appoints George Golumbeski, Ph.D., to Board of Directors

Dr. Golumbeski formerly led corporate and business development at Celgene and NovartisAppointment adds unique skill set to Corbus Board ahead of several key data readouts this summerNorwood, MA, July 08, 2020 (GLOBE NEWSWIRE) — Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system (ECS), today announced the appointment of George Golumbeski, Ph.D., to its Board of Directors.During his corporate career, Dr. Golumbeski held senior leadership positions in business development at Celgene, Novartis, Elan Pharmaceuticals and Schwarz Pharma. In these roles, he drove business strategies that created value, fostered internal and external collaboration, and built creative deal structures and teams...

Continue reading

Guardant Health Announces Collaboration with Janssen to Develop Liquid Biopsy Companion Diagnostic

REDWOOD CITY, Calif., July 08, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Janssen Biotech, Inc. (Janssen) to pursue regulatory approval and commercialization of the Guardant360® CDx as a companion diagnostic for amivantamab, an investigational EGFR-MET bispecific antibody being studied in the treatment of non-small cell lung cancer (NSCLC). The agreement covers the United States, Canada, Japan, and Europe.“Studies continue to show that the full promise of personalized medicine remains out of reach for the majority of patients with advanced non-small cell lung cancer who are not receiving complete genotyping before starting therapy, thus impeding their treatment with the most appropriate therapy,” said AmirAli Talasaz, Ph.D., Guardant Health President. “Our Guardant360...

Continue reading

Systematic Sampling at Novo’s Egina Mining Lease Yields Positive ‘MAK’ Gold Results

VANCOUVER, British Columbia, July 08, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to report positive mobile alluvial Knudson (“MAK”) sampling results from across its 100% owned Egina mining lease, M47/560, indicating widespread gold potential within terrace gravels. The Egina mining lease is a small part of the Company’s overall terrace holdings, representing approximately 5 sq km out of nearly 2,500 sq km, but these systematic sample results provide an encouraging picture of how gold might prove to be distributed over broader parts of the project. Novo’s 2020 Egina exploration program is now ramped back up to full capacity.Summary:MAK sampling has continued apace since Novo resumed its 2020 field season a few weeks ago following a minor delay resulting from COVID-19...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.